Nielka P van Erp Selected Research

Hepatocellular Carcinoma (Hepatoma)

9/2022

Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nielka P van Erp Research Topics

Disease

21	Neoplasms (Cancer) 03/2022 - 12/2007
13	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2016
10	Renal Cell Carcinoma (Grawitz Tumor) 09/2022 - 02/2011
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 01/2014
3	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2016
2	Thyroid Neoplasms (Thyroid Cancer) 09/2022 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	Peritoneal Neoplasms 01/2020 - 01/2019
2	Flushing 01/2020 - 01/2019
2	Neutropenia 10/2019 - 09/2014
2	Hand-Foot Syndrome 09/2014 - 09/2009
2	Adrenocortical Carcinoma 10/2012 - 04/2011
1	Hepatocellular Carcinoma (Hepatoma) 09/2022
1	Fibroma (Fibromatosis) 09/2022
1	Aggressive Fibromatosis (Desmoid) 09/2022
1	Ascites 01/2022
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 01/2022
1	Peritonitis 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Malignant Mesothelioma 01/2020
1	Fatigue 01/2020
1	Hepatitis C 03/2019
1	HIV Infections (HIV Infection) 01/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Facial Nerve Diseases (Facial Nerve Disorders) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Disease Progression 01/2018
1	Chronic Pancreatitis 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Pancreatitis 01/2017
1	Anaplastic Thyroid Carcinoma 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Heart Failure 01/2017
1	Mucositis 09/2014
1	Exanthema (Rash) 09/2014
1	Aphthous Stomatitis (Aphthous Ulcer) 12/2013

Drug/Important Bio-Agent (IBA)

11	Sunitinib (Sutent)FDA Link 01/2022 - 09/2009
9	Pharmaceutical PreparationsIBA 09/2022 - 12/2007
7	Tyrosine Kinase InhibitorsIBA 09/2022 - 12/2009
4	abirateroneIBA 01/2022 - 11/2017
4	pazopanib FDA Link 01/2022 - 01/2014
4	enzalutamideIBA 01/2021 - 11/2016
4	Abiraterone AcetateIBA 01/2021 - 11/2016
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2019
4	Everolimus FDA Link 01/2019 - 11/2016
4	TOR Serine-Threonine KinasesIBA 01/2017 - 12/2013
3	Phosphotransferases (Kinase)IBA 06/2021 - 12/2009
3	Imatinib Mesylate (Gleevec)FDA Link 10/2017 - 12/2007
2	Sorafenib (BAY 43-9006)FDA Link 09/2022 - 02/2013
2	cabozantinibIBA 03/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2021
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 11/2020
2	Docetaxel (Taxotere)FDA Link 01/2021 - 11/2019
2	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 12/2009
2	EnzymesIBA 01/2020 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2019 - 01/2019
2	exemestane (Aromasin)FDA Link 01/2019 - 10/2018
2	AndrogensIBA 01/2018 - 11/2016
2	AcidsIBA 01/2018 - 01/2016
2	Reducing AgentsIBA 01/2018 - 01/2016
1	RNA (Ribonucleic Acid)IBA 12/2021
1	AerosolsIBA 01/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 11/2020
1	Cytostatic AgentsIBA 01/2020
1	Folic Acid AntagonistsIBA 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	Pemetrexed (MTA)FDA Link 01/2020
1	PlatinumIBA 01/2020
1	Hormones (Hormone)IBA 11/2019
1	Antiviral Agents (Antivirals)IBA 03/2019
1	Raltegravir Potassium FDA Link 01/2019
1	etravirine (TMC-125)FDA Link 01/2019
1	elvitegravirIBA 01/2019
1	Nevirapine (Viramune)FDA Link 01/2019
1	dolutegravirIBA 01/2019
1	SolutionsIBA 01/2019
1	VemurafenibIBA 01/2018
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2018
1	Prednisolone (Predate)FDA LinkGeneric 01/2018
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2017
1	IncretinsIBA 01/2017
1	Tamoxifen FDA LinkGeneric 08/2015
1	SU 12662IBA 05/2015
1	1-dodecylpyridoxal (PLD)IBA 09/2014
1	liposomal doxorubicin (Doxil)FDA Link 09/2014
1	MTOR InhibitorsIBA 01/2014

Therapy/Procedure

12	Castration 01/2022 - 11/2016
6	Therapeutics 01/2021 - 12/2013
4	Hyperthermic Intraperitoneal Chemotherapy 01/2021 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
2	Drug Tapering 10/2019 - 01/2018
1	Aftercare (After-Treatment) 01/2022
1	Cytoreduction Surgical Procedures 01/2019
1	Operative Surgical Procedures 01/2019
1	Bariatric Surgery 10/2015